AlphaFold predicted structure
DYM · Q7RTS9

Mean pLDDT
87.1/ 100
Confident
669 residues
Confidence breakdown
- Very high(≥ 90)71%
- Confident(70–90)17%
- Low(50–70)6%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dymeclin
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalPeroxisomal disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+2 more panels — install the extension to see the full list inline on any page.
Dyggve-Melchior-Clausen disease
Smith-McCort dysplasia 1
Smith-McCort dysplasia
hereditary disease
Lethal encephalopathy due to mitochondrial and peroxisomal fission defect
encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1
early-onset non-syndromic cataract
total knee arthroplasty
osteoarthritis, knee
aneurysm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Dymeclin
Necessary for correct organization of Golgi apparatus. Involved in bone development
DYM · Q7RTS9

Mean pLDDT
87.1/ 100
Confident
669 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0